Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 386 for “"Oncolytic"”.
-
Oncolytic Viruses in Lymphoma
… is commonly seen in indolent Lymphoma subtypes. Oncolytic virus (OV) therapies are an emerging treatment option for many malignancies and the first OV has recently been approved by the FDA for the treatment of melanoma. The aim of OV therapy is to effectively replicate within the host, …
-
Improving Direct Oncolytic Effect Of Oncolytic Hsv To Overcome Therapeutic Resistance Of Brain Tumors
… desperately needed. One promising approach is oncolytic viruses (OVs), which achieve tumor regression by two separate oncolytic effects: 1) direct oncolysis of cancer cells through viral infection, replication, and lysis, and 2) stimulation of an antitumor immune response. Oncolytic herpes …
-
Mathematical modelling of oncolytic virotherapy
… is concerned with mathematical modelling of oncolytic virotherapy: the use of genetically modified viruses to selectively spread, replicate and destroy cancerous cells in solid tumours. Traditional spatially-dependent modelling approaches have previously assumed that virus spread is due to …
-
Pharmacological Improvement of Oncolytic Virotherapy
Oncolytic viruses (OV) are an emerging class of anticancer bio-therapeutics that induce antitumor immunity through selective replication in cancer cells. However, the efficacy of OVs as single agents remains limited. We postulate that resistance to oncolytic virotherapy results in part from the …
-
Targeting Tumour Vasculature with Oncolytic Viruses
Oncolytic viruses (OVs) have been engineered or selected for cancer cell-specific infection; however, we have found that following intravenous administration of vesicular stomatitis virus (VSV), tumour cell killing rapidly extends far beyond the initial sites of infection. This Bystander Effect is …
-
Potentiating the Oncolytic Efficacy of Poxviruses
… wild-type poxviruses have emerged as potential oncolytic viruses (OVs), including orf virus (OrfV), and vaccinia virus (VV). Oncolytic VVs have been modified to include attenuating mutations that enhance their tumour selective nature, but these mutations also reduce overall viral fitness in …
-
Optimizing oncolytic adenoviruses for treatment of cholangiocarcinoma
Oncolytic adenoviruses offer a promising new treatment for cancers, especially those which respond poorly to current therapies such as cholangiocarcinoma. However, for clinical use, high selectivity to cancers is required. Thus, I constructed two EGFP-reporter gene expressing viruses, …
-
A Flexible Simulator for Oncolytic Viral Therapy
Developments in recombinant DNA technology have given researchers the ability to modify viruses so that they are highly selective towards cancer cells. Engineered viruses have successfully treated cancer in human trials. In an effort to better understand viral population dynamics in a temporal …
-
Novel Oncolytic Herpesviruses for Breast Cancer Treatment
Oncolytic herpes simplex virus type-1 (HSV-1) has shown great potential as an effective agent for cancer therapy ¨C oncolytic virotherapy. To enhance oncolytic capabilities of previously reported agents, new oncolytic and fusogenic HSV-1 OncSyn and OncdSyn viruses were constructed based on wild …
-
Enhancing Oncolytic Virotherapy Using Functional Genomic Screening
The treatment of cancer patients with oncolytic vaccinia virotherapy has yielded encouraging results in early phase clinical trials, but there are yet unexplored opportunities for improving this therapy that could lead to even better outcomes for patients. To this end, we harnessed the power of …
-
Aptamers as Enhancers of Oncolytic Virus Therapy
Oncolytic viruses promise to significantly improve current cancer treatments through their tumour-selective replication and multimodal attack against cancer cells. However, one of the biggest setbacks for oncolytic virus therapies is the intravenous delivery of the virus, as it can be cleared by …
-
Assessing the oncolytic potential of reovirus reassortants
Type 3 Dearing (T3D) reovirus is an oncolytic virus able to lyse a majority of tumor types. The major drawback is that ∼20% of tumor types are resistant to lysis by T3D and therefore there is a need to improve the oncolytic ability of reovirus to include resistant tumors. When designing an …
-
Harnessing Oncolytic Virus-mediated Anti-tumour Immunity
Treatment of permissive tumours with the oncolytic virus (OV) VSV-Δ51 leads to a robust anti-tumour T cell response, which contributes to efficacy; however, many tumours are not permissive to in vivo treatment with VSV-Δ51. In an attempt to channel the immune stimulatory properties of VSV-Δ51 and …
-
Breast Cancer Immunotherapy Using Magnetised Oncolytic Virus
Abstract Background: Oncolytic viruses (OV) are encouraging new immunotherapies for cancer. OVs, replicate in cancer cells inducing immunogenic cell death (ICD) and activating antitumour immunity. To date, clinical use has focused on intratumoural delivery due to concerns over inadequate tumour …
-
Characterization of Oncolytic Bovine Herpesvirus Type 1
Oncolytic viruses (OV) are a promising alternative cancer therapy due to their specificity and lack of debilitating side effects, such as those which typically accompany conventional therapeutics such as chemotherapy and radiation. Bovine herpesvirus type 1 (BHV-1) is an alphaherpesvirus with the …
-
Enhancement of oncolytic herpes simplex type 1 virotherapy
… excellent safety data, antitumor efficacy of the oncolytic herpes simplex virus type 1 (oHSV-1) in glioblastoma (GBM) patients is not satisfactory. A major enhancement of the oncolytic activity of the oHSV-1 is necessary to eradicate the GBM in clinics. To enhance the efficacy and tumour …
-
Development of sindbis virus as an oncolytic agent
… viruses currently in development for use as oncolytic agents.</p> <p>Sindbis virus is a member of the Alphavirus family that has shown promising anti-cancer activity in pre-clinical models. A concern for the clinical use of Sindbis virus as an anticancer agent is its pathology in humans, …
-
Engineering Large DNA Viruses for Enhanced Oncolytic Virotherapy
Oncolytic viruses (OVs) offer a promising approach to cancer immunotherapy, but challenges in safety, efficacy, and engineering complex platforms remain. This thesis addresses these hurdles with novel tools and strategies. We designed an array of chemically inducible systems, controlled by …
-
Bio-Engineering Vaccinia Viruses for Increased Oncolytic Potential
… elements that together create an optimal “oncolytic engine”. Using a transposon insertion strategy and deep sequencing of viral populations we systematically examined Vaccinia genes that do or do not play a role in the therapeutic activity of the virus. Our studies allowed us to identify a …
Page 1 of 20